RxDoctor Payments Data

Jennifer Greene Welch

Pediatric Hematology-Oncology · Providence, RINPI 1174741656

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,000 of the $1,225 with a category attached, or 81.7%. Amgen accounts for 81.7% of it on its own, with 2 other manufacturers making up the rest. 2024 is the largest year on record at $1,000, 5.7 times the $175 reported in 2019.

$1,225in general payments, 2019–2025

Across 5 payments — averaging $244.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • AstraZeneca$150
  • Servier Pharmaceuticals LLC$75
$437,506in research payments, 2019–2025

Across 15 payments — averaging $29,167 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Jazz Pharmaceuticals Inc.$416K
  • AbbVie$8K
  • Pfizer$8K
  • Incyte Corporation$6K

What the payments were for

  • Consulting fees$1,00082%
  • Speaking & faculty fees$15012%
  • Food & beverage$756%

General payments by program year

19
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen1$1,000
AstraZeneca1$150
Servier Pharmaceuticals LLC3$75

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric hematology-oncology providers in Rhode Islandto place this figure against a meaningful peer group, so we don't.

Other pediatric hematology-oncology in Providence

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →